Figure 2From: Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysisHazard ratio dose–response curve (dark line) and upper and lower limits of the confidence interval (lighter lines) for body mass index for each survival outcome. (A) Overall Mortality. (B) Breast cancer mortality. (C) Recurrence. Estimates were adjusted for all the variables in the full model.Back to article page